Mayo Clinic Hospital-Rochester, St. Marys Campus - PPDS

Minneapolis, Minnesota 55455

0 studies enrolling now · 1 studies all time

What they study most

HER2-positive Breast Cancer

Studies at this site

• An Expanded Access Study to Provide at Home Subcutaneous Administration of Pertuzumab and Trastuzumab Fixed-Dose Combination (PH FDC SC) for Patients With HER2-Positive Breast Cancer During the COVID-19 Pandemic — APPROVED_FOR_MARKETING